New study shows that beta cell fragility may contribute to the risk of both type 1 and type 2 diabetes. Continue Reading »
You can help more people with diabetes
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
New study shows that beta cell fragility may contribute to the risk of both type 1 and type 2 diabetes. Continue Reading »
How many people have type 1? What are the barriers to using new therapies? What outcomes matter beyond A1c? Continue Reading »
Views on FDA regulation, pipeline updates, and first vs. next-generation systems. Continue Reading »
Type 1 diabetes has been prevented and cured in more than 500 ways in mice, but never in humans. nPOD researchers are trying to change that, one donated organ at a time. Continue Reading »
TZD drug pioglitazone becomes second-ever diabetes drug to reduce heart disease and first to reduce strokes. Who might this benefit most? Continue Reading »
Incredible presentation from CEO Derek Rapp on the state of the foundation. Plus, updates on the Bionic Pancreas and ViaCyte! Continue Reading »
A new study from Dr. Doug Melton’s team provides hope for the future of stem cell treatment in diabetes. But there’s still a long way to go. Continue Reading »
